Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfuzosin for Stone Expulsion Following SWL
NCT00409227Phase 2Unknown
- Sponsor
- Shamir Medical Center
- Start
- Dec 2006
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alfuzosin in urolithiasis, sponsored by Shamir Medical Center. Status: unknown.
02
Drugs
alfuzosin
03
Conditions
urolithiasis
Beyond the preview
Go deeper on NCT00409227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00409227.